Interferon treatment of hepatitis C indications

Treatment of acute hepatitis C are targeted, timely treatment to prevent chronic. All chronic hepatitis C patients have the best treatment, but only part of selected only for interferon treatment.
The main indications for the development of cirrhosis is easy to high-risk patients, clinical ALT continued or repeated increased HCV-RNA positive, a liver biopsy of the area to the bridge or fibrosis, or at least moderate inflammation and necrosis. Another group ALT increased necrosis liver biopsy only mild inflammation, no fibrosis patients, whether treatment should be immediately, it is not clear, follow-up may be observed, every 3-5 years for a liver biopsy to be decided. Less than 18 years old and more than 60-year-old patient, and do not recommend treatment with interferon.
For normal ALT of HCV infected patients, the available information does not prove that interferon good, but can cause increased ALT, the treatment is not temporary. ORIGINAL: drug abuse or squandering, to stop drug abuse or alcohol only after six months of treatment. Chronic hepatitis C merger HIV infection, such as a stable condition, clinical and immune function as well, in accordance with the above dosage and treatment with interferon treatment.
Any serious depression patients medical history, blood cells decreased, hyperthyroidism, renal transplantation and autoimmune diseases, should be a contraindication.